Statement of Principles concerning osteogenesis imperfecta No. 35 of 2015

Administered by Department of Veterans' Affairs

Legislation au F2014L01848 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 35 of 2015

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), revokes Instrument No. 59 of 2007, determined under subsection 196B(2) of the VEA concerning osteogenesis imperfecta.
  2. The Authority is of the view that there is sound medical-scientific evidence that indicates that osteogenesis imperfecta and death from osteogenesis imperfecta can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles, Instrument No. 35 of 2015 concerning osteogenesis imperfecta.  This Instrument will in effect replace the revoked Statement of Principles.
  3. The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.
  4. The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting osteogenesis imperfecta or death from osteogenesis imperfecta, with the circumstances of that service.

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 31 October 2012 concerning osteogenesis imperfecta in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

6.             The contents of this Instrument are in similar terms as the revoked Instrument.  Comparing this Instrument and the revoked Instrument, the differences include:

  • revising the definition of 'osteogenesis imperfecta' in clause 3;
  • revising the definitions of 'ICD-10-AM code' and 'relevant service' in clause 6; and
  • specifying a date of effect for the Instrument in clause 8.

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to osteogenesis imperfecta in the Government Notices Gazette of 31 October 2012, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

10.         The determining of this Instrument finalises the investigation in relation to osteogenesis imperfecta as advertised in the Government Notices Gazette of 31 October 2012.

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 35 of 2015

Kind of Injury, Disease or Death: Osteogenesis imperfecta

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have osteogenesis imperfecta;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting osteogenesis imperfecta with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes;
  • replaces Instrument No. 59 of 2007; and
  • reflects developments in the available sound medical-scientific evidence concerning osteogenesis imperfecta which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA) provide a framework for the assessment and provision of medical treatment and compensation to veterans and current or former members of the Defence Force. The Repatriation Medical Authority (the Authority) under the VEA has issued Instrument No. 35 of 2015 to address the medical condition of osteogenesis imperfecta. This instrument revokes the previous Instrument No. 59 of 2007 and incorporates updated sound medical-scientific evidence to clarify the circumstances in which osteogenesis imperfecta and death from osteogenesis imperfecta can be related to specific kinds of service. The Instrument specifies the factors that must exist for a reasonable hypothesis to be raised connecting osteogenesis imperfecta with the service rendered, facilitating claims under the VEA and MRCA. This legislative instrument is intended to improve the medico-scientific quality of outcomes under the VEA and MRCA and ensures compatibility with human rights as it promotes the rights of veterans, current and former Defence Force members, and their dependents. The Authority undertook an investigation into osteogenesis imperfecta, advertised in the Government Notices Gazette of 31 October 2012, and invited submissions from relevant stakeholders, although none were received. This instrument reflects the commencement of the MRCA and updates the definition of osteogenesis imperfecta, ICD-10-AM code, and relevant service, while specifying the date of effect. The Authority ensures that this instrument is compatible with the human rights and freedoms recognised in international instruments, promoting the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health.

Scope and Application

The Repatriation Medical Authority Instrument No. 35 of 2015, concerning osteogenesis imperfecta, is determined under the Veterans' Entitlements Act 1986 and applies to individuals, including veterans and current or former Defence Force members, who have sustained osteogenesis imperfecta as a result of their service. This instrument replaces the previously revoked Instrument No. 59 of 2007, reflecting updated medical-scientific evidence. The Instrument applies to service rendered under various categories such as operational, peacekeeping, hazardous, British nuclear test defence service, warlike, and non-warlike service, provided that specific conditions relating to osteogenesis imperfecta and service are met. The Instrument facilitates the assessment of claims for compensation under the Military Rehabilitation and Compensation Act 2004, ensuring that compensation and medical treatment can be extended to eligible persons. The instrument is compatible with human rights, promoting rights to social security, an adequate standard of living, and the highest attainable standard of physical and mental health. This legislative instrument ensures that the conditions for benefit eligibility are reasonable, proportionate, and transparent, thereby upholding human rights while addressing the specific needs of affected veterans and Defence Force members.

Key Provisions

The Repatriation Medical Authority, as outlined in Instrument No. 35 of 2015 under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), revokes Instrument No. 59 of 2007 concerning osteogenesis imperfecta. This new instrument provides a Statement of Principles that determines the minimum factors necessary to establish a reasonable hypothesis linking osteogenesis imperfecta or death from it with specific kinds of service, including operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, and warlike or non-warlike service under the MRCA. The instrument revises definitions and specifies an effective date, clarifying the application of the Statement of Principles for both the VEA and the MRCA. Under this legislation, the Repatriation Medical Authority imposes obligations on claimants, the Repatriation Commission, and other relevant parties. Claimants must demonstrate that they meet the specified factors outlined in the Statement of Principles to link their osteogenesis imperfecta with their service. The Repatriation Commission is required to assess these claims based on the sound medical-scientific evidence provided and determine eligibility for compensation and medical treatment. The Authority is also obligated to ensure that these assessments are fair, transparent, and based on the latest available evidence. The Act provides for specific offences, penalties, and consequences for non-compliance. While the explanatory notes do not detail specific criminal offences, breaches of the requirements for eligibility and false claims could potentially result in civil penalties, including fines and the recovery of wrongly paid benefits. Additionally, providing false information during the claims process could be considered a criminal offence under other related legislation, potentially leading to prosecution, fines, and imprisonment. Overall, this legislative instrument ensures that the assessment and determination of benefits and compensation for osteogenesis imperfecta are based on sound medical-scientific evidence, thereby protecting the rights of veterans and service personnel. It promotes human rights by ensuring that the conditions for benefit are reasonable, proportionate, and transparent, facilitating access to social security, healthcare, and an adequate standard of living for those affected.

Legal classification tags

Area of Law
Veterans' Law
Health Law
Administrative Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Repeal & Amendment
Reporting & Disclosure Obligations
Compliance Obligations
Rights & Protections

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.